SOURCE: Oracle Corporation

Oracle Corporation

March 29, 2011 02:00 ET

Oracle Introduces Oracle® Health Sciences Clinical Development Center Version 3.1

New Version Accelerates the Data Stream Throughout the Clinical Trial Process for Increased Productivity and Efficiency

GENEVA--(Marketwire - March 29, 2011) - DIA EuroMeeting 2011 -- Oracle (NASDAQ: ORCL)

News Facts

  • Oracle today announced the availability of Oracle® Health Sciences Clinical Development Center 3.1, a centralized solution for integrating, managing and analyzing clinical trial information.
  • The release provides new integration, increased automation, and expanded data standardization to enable accelerated processing of clinical trial data from multiple sources in a variety of formats and increased user productivity from capture through submission. 
  • Oracle Health Sciences Clinical Development Center 3.1 features automated data load and new execution triggers to increase the timeliness and accuracy of data analysis. The system now automatically reruns routines and programs against the most recent data and notifies users of data and study changes as they occur. The system can also be personalized to notify users of specific events that require their attention.
  • Newly enhanced governance capabilities allow for the creation of validated libraries to drive standardization, control and reuse of data models, macros, and programs across studies. These features help increase the quality, consistency and reliability of data delivery, while accelerating study set up time and decreasing validation efforts required for each study. 
  • Version 3.1 also features a pre-built integration with Oracle Health Sciences InForm GTM electronic data capture (EDC) solution, as well as enhanced support for Medidata Rave clinical data management and EDC platform, automating the set up of Medidata Rave studies and data loading to save time and reduce potential for error. Oracle Health Sciences Clinical Development Center 3.1 now also supports the use of Interactive SAS for program development, and integrates with Oracle's Siebel Clinical Trial Management System to help auto load study metadata. 
  • To accommodate the increasingly global nature of the clinical trial process, the latest version also supports the management of data from studies in multiple languages.

Supporting Quotes

  • "As clinical trials continue to expand in scope, complexity, and cost, trial sponsors and contract research organizations require solutions that enable them to efficiently aggregate and process rapidly growing volumes of clinical trial data emanating from multiple sources," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "The Oracle Clinical Development Center 3.1, via its new integration capabilities and standardization enhancements, enables organizations to further accelerate data aggregation and reconciliation, streamline preparation for analysis, automate the downstream analysis process, and ensure control and compliance."

Supporting Resources

About Oracle
Oracle is the world's most complete, open, and integrated business software and hardware systems company. For more information about Oracle, please visit our Web site at

Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Information